10-K Filing

Company

Travere Therapeutics, Inc.

Filed

June 13, 2013

Period of Report

December 31, 2012

Accession Number

0001193805-13-001119

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →